#ASCO19: Sanofi sets the stage for a late arrival of their multiple myeloma drug isatuximab — with J&J and Genmab laying in wait

#ASCO19: Sanofi sets the stage for a late arrival of their multiple myeloma drug isatuximab — with J&J and Genmab laying in wait

Submitted by admin on June 2, 2019 - 1:18pm
Source: 
Endpoints
News Tags: 
Sanofi
Multiple Myeloma
isatuximab
ASCO 2019
Headline: 
#ASCO19: Sanofi sets the stage for a late arrival of their multiple myeloma drug isatuximab — with J&J and Genmab laying in wait
snippet: 

Pharma giant Sanofi is making a rare appearance in the front ranks of the newsmakers at ASCO this year with the details on their Phase III success story for their multiple myeloma drug isatuximab.

Do Not Allow Advertisers to Use My Personal information